{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:34:16Z","timestamp":1723199656146},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Warfare organophosphates nerve agents constitute one of the prime threats to mankind on the battlefield and in the scenario of civilian terror. Exposure to\u00a0organophosphate (OP) nerve agents dose-dependently result in incapacitation. They affect multiple organs, but the eye is one of the first and most frequently affected. Ocular OP insult may result in long-term miosis, impaired visual function, and ocular pain thus inducing functional incapacitation. The currently recommended military medical doctrine of using 1% atropine eye drops is far from being the optimal treatment. Although effective in reducing ocular pain and the miotic response, this treatment induces long-term mydriasis and cycloplegia promoting photophobia and restricted accommodation, which may result in further impairment in visual function. An optimal treatment must ameliorate the long-term ocular insult enabling rapid return of normal visual function, while avoiding the induction of mydriasis and cycloplegia side effects, which could possibly worsen the visual performance. Optimal treatment should also keep effects of misuse to a minimum. Work done in recent years examined treatments with various anticholinergic drugs alone or used in combination with oxime treatments and may offer improved efficacy in ameliorating the ocular insult. This review is a summary of the applied research in animals and will discuss clinical implications and possible alterations in treatment protocols following OP exposure. Taken together the data points toward the use of topical low concentrations of potent anticholinergic ophthalmic drops such as atropine or homatropine, which rapidly ameliorate the long-term OP-induced ocular insult.<\/jats:p>","DOI":"10.1093\/toxsci\/kfaa095","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T19:11:29Z","timestamp":1592248289000},"page":"1-10","source":"Crossref","is-referenced-by-count":4,"title":["Broad Spectrum Treatment for Ocular Insult Induced by Organophosphate Chemical Warfare Agents"],"prefix":"10.1093","volume":"177","author":[{"given":"Ariel","family":"Gore","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"2020101315044991400_kfaa095-B7804232","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S0952523898154020","article-title":"Retinal image quality in the rodent eye","author":"Artal","year":"1998","journal-title":"Vis. Neurosci."},{"key":"2020101315044991400_kfaa095-B1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1440-1681.2001.03561.x","article-title":"Effect of \u03b1adrenoreceptor blockade on the 0.4 Hz sympathetic rhythm in conscious rats","volume":"28","author":"Barres","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2020101315044991400_kfaa095-B2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1167\/iovs.02-0468","article-title":"Latency of the pupil light reflex: Sample rate, stimulus intensity, and variation in normal subjects","volume":"44","author":"Bergamin","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2020101315044991400_kfaa095-B3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archopht.1969.00990020675017","article-title":"Effect of chronic cholinesterase inhibitor treatment","volume":"82","author":"Bito","year":"1969","journal-title":"Arch. Ophthalmol."},{"key":"2020101315044991400_kfaa095-B4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00204-019-02401-0","article-title":"Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-blood VX vapor exposure in freely moving rats","volume":"93","author":"Bloch-Shilderman","year":"2019","journal-title":"Arch. Toxicol."},{"key":"2020101315044991400_kfaa095-B5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1099-1263(199811\/12)18:6<393::AID-JAT528>3.0.CO;2-0","article-title":"Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents","volume":"18","author":"Brown","year":"1998","journal-title":"J. Appl. Toxicol."},{"key":"2020101315044991400_kfaa095-B6","author":"Callaway","year":"1971"},{"key":"2020101315044991400_kfaa095-B7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2006.06.008","article-title":"The acute treatment of nerve agent exposure","volume":"249","author":"Cannard","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"2020101315044991400_kfaa095-B8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/24734306.2017.1373503","article-title":"Toxic chemical weapons of assassination and warfare: Nerve agents VX and sarin","volume":"1","author":"Chai","year":"2017","journal-title":"Toxicol. Commun."},{"key":"2020101315044991400_kfaa095-B9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/jop.2005.21.182","article-title":"Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures","volume":"21","author":"Dabisch","year":"2005","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"2020101315044991400_kfaa095-B10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15569520802064376","article-title":"Gender difference in the miotic potency of soman vapor in rats","volume":"27","author":"Dabisch","year":"2008","journal-title":"Cutan. Ocul. Toxicol."},{"key":"2020101315044991400_kfaa095-B11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jat.2550140502","article-title":"Review of oximes available for treatment of nerve agent poisoning","volume":"14","author":"Dawson","year":"1994","journal-title":"Appl. Toxicol."},{"key":"2020101315044991400_kfaa095-B12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces need for better anti-sarin drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat. Med."},{"key":"2020101315044991400_kfaa095-B13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/toxsci\/kfx119","article-title":"Optimization of the ocular treatment following organophosphate nerve agent insult","volume":"159","author":"Egoz","year":"2017","journal-title":"Toxicol. Sci."},{"key":"2020101315044991400_kfaa095-B14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archopht.1967.00980020742005","article-title":"Mydriatic effect of four drugs determined with pupillograph","volume":"77","author":"Gambill","year":"1967","journal-title":"Arch. Ophthalmol."},{"key":"2020101315044991400_kfaa095-B15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2007.11.004","article-title":"Determination of miosis threshold from whole-body vapor exposure to sarin in African green monkeys","volume":"244","author":"Genovese","year":"2008","journal-title":"Toxicology"},{"key":"2020101315044991400_kfaa095-B16","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/bph.12586","article-title":"Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats","volume":"171","author":"Gore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"2020101315044991400_kfaa095-B17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/toxsci\/kfs009","article-title":"Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats","volume":"126","author":"Gore","year":"2012","journal-title":"Toxicol. Sci."},{"key":"2020101315044991400_kfaa095-B18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/toxsci\/kfv092","article-title":"Synergism between anticholinergic and oxime treatments against sarin-induced ocular insult in rats","volume":"146","author":"Gore","year":"2015","journal-title":"Toxicol. Sci."},{"key":"2020101315044991400_kfaa095-B19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.toxlet.2019.08.002","article-title":"Ocular surface histopathological insult following sarin and VX exposure and potential treatments in the rat model","volume":"314","author":"Gore","year":"2019","journal-title":"Toxicol. Lett."},{"key":"2020101315044991400_kfaa095-B20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI103615","article-title":"Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate)","volume":"37","author":"Grob","year":"1958","journal-title":"J. Clin. Invest."},{"key":"2020101315044991400_kfaa095-B21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15376510903234773","article-title":"In vivo oxime administration does not influence Ellman acetylcholinesterase assay results","volume":"19","author":"Guarisco","year":"2009","journal-title":"Toxicol. Mech. Methods"},{"key":"2020101315044991400_kfaa095-B22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11940-004-0035-2","article-title":"Insecticides","volume":"6","author":"Holstege","year":"2004","journal-title":"Curr. Treat. Options Neurol."},{"key":"2020101315044991400_kfaa095-B23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0749-0704(05)70374-2","article-title":"Chemical warfare. Nerve agent poisoning","volume":"13","author":"Holstege","year":"1997","journal-title":"Crit. Care Clin."},{"key":"2020101315044991400_kfaa095-B24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/08958370500306131","article-title":"Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the Gottingen minipig: Effects of exposure concentration and duration","volume":"18","author":"Hulet","year":"2006","journal-title":"Inhal. Toxicol."},{"key":"2020101315044991400_kfaa095-B25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0002-9394(61)90910-2","article-title":"The neutralization of cholinesterase inhibition by various oximes and by atropine","volume":"52","author":"Hunter","year":"1961","journal-title":"Am. J. Ophthalmol."},{"key":"2020101315044991400_kfaa095-B26","first-page":"21010","author":"Hurst","year":"2007"},{"key":"2020101315044991400_kfaa095-B27","author":"Johns","year":"1952"},{"key":"2020101315044991400_kfaa095-B28","volume-title":"The Problem of Chemical and Biological Warfare","author":"Robinson,","year":"1971"},{"key":"2020101315044991400_kfaa095-B29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1081\/CLT-120015840","article-title":"Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents","volume":"40","author":"Kassa","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"2020101315044991400_kfaa095-B30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/milmed\/166.suppl_2.23","article-title":"Psycho-physiological effects of the terrorist sarin attack on the Tokyo subway system","volume":"166","author":"Kawana","year":"2001","journal-title":"Mil. Med."},{"key":"2020101315044991400_kfaa095-B31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1113\/expphysiol.1988.sp003171","article-title":"An evaluation of the effectiveness of intramuscular atropine or homatropine eyedrops in preventing the effects of physostigmine eyedrops on human vision","volume":"73","author":"Kay","year":"1988","journal-title":"Q. J. Exp. Physiol."},{"key":"2020101315044991400_kfaa095-B32","volume-title":"The Pharmacological Basis of Therapeutics","author":"Koelle","year":"1975","edition":"5th ed."},{"key":"2020101315044991400_kfaa095-B33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jat.2550140211","article-title":"Pharmacology of organophosphates","volume":"14","author":"Koelle","year":"1994","journal-title":"J. Appl. Toxicol."},{"key":"2020101315044991400_kfaa095-B34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0773.1976.tb03124.x","article-title":"The effect of locally applied cholinesterase inhibitors and oximes on the acetylcholinesterase activity in different parts of the guinea-pig eye","volume":"38","author":"Lund-Karlsen","year":"2009","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"2020101315044991400_kfaa095-B35","first-page":"399","article-title":"The effect of the oxime HI-6 on miosis induced by topical administration of sarin and VX in the rabbit eye","volume":"47","author":"Macic","year":"1990","journal-title":"Vojnosanit. Pregl."},{"key":"2020101315044991400_kfaa095-B36","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0002-9394(58)91271-6","article-title":"Evaluation and use of oximes in ophthalmology","volume":"46","author":"Mamo","year":"1958","journal-title":"Am. J. Ophthalmol"},{"key":"2020101315044991400_kfaa095-B37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archopht.1940.00860130378006","article-title":"Cycloplegia and mydriasis by use of atropine, scopolamine and homatropine-paredrine","volume":"23","author":"Marron","year":"1940","journal-title":"Arch. Ophthalmol."},{"key":"2020101315044991400_kfaa095-B38","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0140-6736(95)92637-2","article-title":"Sarin poisoning in Tokyo subway","volume":"345","author":"Masuda","year":"1995","journal-title":"Lancet"},{"key":"2020101315044991400_kfaa095-B39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0028-3908(84)90241-7","article-title":"Effects of DFP on iridic metabolism and release of acetylcholine and on pupillary function in the rat","volume":"23","author":"Mattio","year":"1984","journal-title":"Neuropharmacology"},{"key":"2020101315044991400_kfaa095-B40","author":"McKee","year":"1949"},{"key":"2020101315044991400_kfaa095-B41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(58)90580-4","article-title":"Effect of atropine on the heart-rate","volume":"272","author":"Morton","year":"1958","journal-title":"Lancet"},{"key":"2020101315044991400_kfaa095-B42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1476-5381.1973.tb06917.x","article-title":"Cyclopentolate in treatment of sarin miosis","volume":"48","author":"Moylan-Jones","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"2020101315044991400_kfaa095-B43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1289\/ehp.9410218","article-title":"Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: Implications for public protection","volume":"102","author":"Munro","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"2020101315044991400_kfaa095-B44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjo.80.11.1023","article-title":"Ocular symptoms due to organophosphorus gas (sarin) poisoning in Matsumoto","volume":"80","author":"Nohara","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"2020101315044991400_kfaa095-B45","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/BF01700667","article-title":"Secondary exposure of medical staff to sarin vapor in the emergency room","volume":"21","author":"Nozaki","year":"1995","journal-title":"Intensive Care Med."},{"key":"2020101315044991400_kfaa095-B46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00007611-199706000-00002","article-title":"Sarin poisoning on Tokyo subway","volume":"90","author":"Ohbu","year":"1997","journal-title":"South Med. J."},{"key":"2020101315044991400_kfaa095-B47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/jocn.2001.1020","article-title":"Clinical features on nerve gas terrorism in Matsumoto","volume":"9","author":"Okudera","year":"2002","journal-title":"J. Clin. Neurosci."},{"key":"2020101315044991400_kfaa095-B48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0196-0644(96)70052-5","article-title":"Report on 640 victims of the Tokyo subway sarin attack","volume":"28","author":"Okumura","year":"1996","journal-title":"Ann. Emerg. Med."},{"key":"2020101315044991400_kfaa095-B49","volume-title":"Handbook of Toxicology of Chemical Warfare Agents","author":"Okumura","year":"2009"},{"key":"2020101315044991400_kfaa095-B50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/toxsci\/kfg166","article-title":"Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction","volume":"75","author":"Raveh","year":"2003","journal-title":"Toxicol. Sci."},{"key":"2020101315044991400_kfaa095-B51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00333427","article-title":"Accidental exposure to sarin: Vision effects","volume":"56","author":"Rengstorff","year":"1985","journal-title":"Arch. Toxicol."},{"key":"2020101315044991400_kfaa095-B52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jat.2550140213","article-title":"Vision and ocular changes following accidental exposure to organophosphates","volume":"14","author":"Rengstorff","year":"1994","journal-title":"J. Appl. Toxicol."},{"key":"2020101315044991400_kfaa095-B53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/M13-2799","article-title":"Lessons learned from the Syrian sarin attack: Evaluation of a clinical syndrome through social media","volume":"160","author":"Rosman","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"2020101315044991400_kfaa095-B54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/09546559908427535","article-title":"Terrorism and the use of weapons of mass destruction: From where the risk","volume":"11","author":"Schmid","year":"1999","journal-title":"Terror. Political Violence"},{"key":"2020101315044991400_kfaa095-B55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0306-3623(93)90024-R","article-title":"Subtype of muscarinic receptors mediating relaxation and contraction in the rat iris dilator smooth muscle","volume":"24","author":"Shiraishi","year":"1993","journal-title":"Gen. Pharmacol."},{"key":"2020101315044991400_kfaa095-B56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jat.2550140212","article-title":"Clinical effects of organophosphorus cholinesterase inhibitors","volume":"14","author":"Sidell","year":"1994","journal-title":"J. Appl. Toxicol."},{"key":"2020101315044991400_kfaa095-B57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0041-008X(74)90195-1","article-title":"The reactivatibility of cholinesterase inhibited by VX and sarin in man","volume":"27","author":"Sidell","year":"1974","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2020101315044991400_kfaa095-B58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21236\/ADA398241","volume-title":"Medical Aspects of Chemical and Biological Warfare (Textbook of Military Medicine. Part I. Warfare, Weaponry, and the Casualty)","author":"Sidell","year":"1997"},{"key":"2020101315044991400_kfaa095-B59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1476-5381.1980.tb07042.x","article-title":"Subsensitivity to cholinoceptor stimulation of the human iris sphincter in situ following acute and chronic administration of cholinomimetic miotic drugs","volume":"69","author":"Smith","year":"1980","journal-title":"Br. J. Pharmacol."},{"key":"2020101315044991400_kfaa095-B60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1471-4159.1980.tb03712.x","article-title":"Correlations between acetylcholinesterase activity in guinea-pig iris and pupillary function: A biochemical and pupillographic study","volume":"35","author":"Soli","year":"1980","journal-title":"J. Neurochem."},{"key":"2020101315044991400_kfaa095-B61","author":"Swiatek","year":"1999"},{"key":"2020101315044991400_kfaa095-B62","volume-title":"Ophthalmic Care of the Combat Casulty Office of the Surgen General at TMM Publications Borden Institute, Walter Reed Army Medical Center Washington, DC 20307-5001","author":"Trudo","year":"2003"},{"key":"2020101315044991400_kfaa095-B63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0041-008X(03)00216-3","article-title":"Toxicokinetics of the nerve agent (+\/\u2212)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration","volume":"191","author":"Van der Schans","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2020101315044991400_kfaa095-B64","first-page":"5","article-title":"Evaluation of antidotal efficacy of atropine sulfate and pralidoxime chloride given by autoinjectors against nerve agent (sarin) toxicity","volume":"5","author":"Vijayaraghavan","year":"2007","journal-title":"J. Med. CBR Defense"},{"key":"2020101315044991400_kfaa095-B65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2011.09.004","article-title":"Multifunctional drugs as novel antidotes for organophosphates' poisoning","volume":"290","author":"Weissman","year":"2011","journal-title":"Toxicology"},{"key":"2020101315044991400_kfaa095-B66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/faat.1994.1114","article-title":"Erythrocyte and plasma cholinesterase activity in male and female rhesus monkeys before and after exposure to sarin","volume":"23","author":"Woodard","year":"1994","journal-title":"Fundam. Appl. Toxicol"},{"key":"2020101315044991400_kfaa095-B67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: Acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"2020101315044991400_kfaa095-B68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0140-6736(95)92170-2","article-title":"Sarin poisoning in Matsumoto","volume":"346","author":"Yanagisawa","year":"1995","journal-title":"Jpn. Lancet"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfaa095\/33691691\/kfaa095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/177\/1\/1\/33878753\/kfaa095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/177\/1\/1\/33878753\/kfaa095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T20:40:47Z","timestamp":1602621647000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/177\/1\/1\/5862025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,27]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfaa095","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,6,27]]}}}